HOME >> BIOLOGY >> NEWS
21st Century model of healthcare focuses on the family before and after genetic testing

An article in the recent issue of Family Process presents the family-centered model created to guide the psychological and social implications of genetic testing. The rapidly growing availability of genetic testing to learn about future disease risk poses a number of clinical and ethical dilemmas for patients, their families and healthcare professionals. "The need for a family-based approach that deals with the psychosocial consequences of acquiring and living with genetic information has never been more urgent," state the authors. Living with genetic risk information often continues for a lifetime. To meet this challenge, biopsychosocial models of healthcare will need to shift from a focus on intervention after disease onset to more predictive and preventive approaches before symptoms appear.

The model clusters genomic disorders based on key characteristics that define types of disorders with similar patterns of psychosocial demands over time. Key disease variables include: the likelihood of developing a disorder based on specific genetic mutations, overall clinical severity, timing of clinical-onset in the life cycle, and whether effective treatment interventions exist to alter disease onset and/or progression.

This model is published in the current issue of Family Process. Media wishing to receive a pdf of this article please contact journalnews@bos.blackwellpublishing.net

Family Process is an international, multidisciplinary, peer-reviewed journal committed to publishing original articles, including theory and practice, philosophical underpinnings, qualitative and quantitative clinical research, and training in couple and family therapy, family interaction, and family relationships with networks and larger systems. It is published on behalf of the Family Process Institute.

John S. Rolland is Clinical Professor of Psychiatry and Co-Director of the Center for Family He
'"/>

Contact: Jill Yablonski
Journalnews@bos.blackwellpublishing.net
781-388-8448
Blackwell Publishing Ltd.
24-Feb-2005


Page: 1 2

Related biology news :

1. Huntingtons disease study shows animal models on target
2. Stem cell therapy rescues motor neurons in ALS model
3. MIT model could predict cells response to drugs
4. Drug protects brain cells in Huntingtons disease model, researchers find
5. New model for autism suggests women carry the disorder and explains age as a risk factor
6. New treatment model for HIV
7. A first-principles model of early evolution
8. Virginia Tech researchers to study poplar tree as model biomass crop
9. Scripps research scientists show protein accelerates breast cancer progression in animal models
10. Better chemistry through living models
11. Gene therapy delivery of nerve growth factors reverses erectile dysfunction in animal model

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... ... June 04, 2020 , ... Greffex, a pioneering vaccine and gene therapy company ... “Neil understands the need for a global perspective to make an impact in a ... Bush will serve as an independent, director of the company. , “The Greffex board ...
(Date:5/30/2020)... ... May 29, 2020 , ... eInfochips, a leading ... has collaborated with EchoNous Inc. to develop the cloud-based connected health KOSMOS platform ... function, which has been clinically tested versus expert measurements, yielding improved results in ...
(Date:5/28/2020)... ... May 27, 2020 , ... Today bioinformatics leader hc1® ... uniquely combines lab testing insights and hc1’s exclusive Local Risk Index in a ... safety of employees returning to the workplace. , “Some of the best ways ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... (PRWEB) , ... June 26, 2020 , ... ... association representing security solutions providers, today announced its strong opposition to the recently ... bill would impose a blanket ban on most federal use of nearly all ...
(Date:6/23/2020)... PORTLAND, Ore. (PRWEB) , ... June 23, 2020 ... ... advancement of innovative CNS therapies, today announced that it has filed an Investigational ... initiate a Phase 2b clinical trial of its lead drug candidate NBTX-001 in ...
(Date:6/11/2020)... ... 09, 2020 , ... Reducing carbon emissions has been and will continue to ... stock market dips, ways to reduce CO2 is something we can’t avoid. , ... the biofuels being produced today are created from recycled cooking oil or crops. Unfortunately, ...
(Date:5/28/2020)... ... May 28, 2020 , ... Genedata, the leading provider of ... Screener ® 17.0, the latest version of its enterprise software for the automated ... Genedata will host a webinar on June 10, 2020, detailing and demonstrating the ...
Breaking Biology Technology:
Cached News: